Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
acquiror, ADF, Aerosol, Allen, amino, amplified, andCustom, Apothecary, ASL, autoimmunity, bad, buying, Cantor, CAP, ceiling, Central, ChoiceTM, citrate, clause, conveniently, copyright, cure, cystine, cystinuria, Daraprim, default, differentiating, DiGenova, disorder, dysfunction, ear, easily, ED, Elmiron, encumbrance, endocrine, erectile, Fitzgerald, floor, Folcroft, foreclose, fulsome, fungal, headquartered, immune, incurrence, indefinite, inherited, intent, intermittent, IP, Jonathan, JT, leader, leaving, Legacy, lender, leucovorin, licensor, lien, LSAF, margin, matching, mucosa, Neck, Nguyen, nineteen, noncreditable, noncurrent, nose, NPA, NRV, OfferingSM, otolaryngology, ourcustom, outbreak, outfitting, outlined, overlooked, Pennsylvania, plaintiff, pleading, popularity, potassium, powder, practitioner, pregnant, preliminarily, preliminary, Principi, pyrimethamine, ready, reconstituted, reconstitution, redundancy, refill, reluctant, renaming, repay, representation, repurchase, repurchasing, residual, retrospective, retrospectively, sinonasal, SinuTopic, sponsorship, Statista, Stericheck, stored, TAG, TechnologyTM, theAmerican, therefrom, Thiola, Thousand, throat, tiopronin, TOHC, transportation, transported, Trimoxi, Trinh, Triple, unified, urethra, Utah, variation, vasoactive, warranty, wasted, weakened
Removed:
accredited, Accudel, accurate, acquirer, actively, anticipation, appointed, CA, commence, commencing, commonly, communication, Concurrent, conform, contemplated, deem, DermaStar, disclose, dismissal, dismissing, distinction, Dr, employ, exploration, facilitate, fill, float, force, forward, fractional, global, higher, human, iii, Impracor, initiating, interested, internally, introductory, investigator, iv, Journal, legally, mandatory, MDB, mineral, modification, optimal, ordered, OTC, partnership, pertaining, Pharmacopeia, placement, positive, predict, pressure, print, private, quotation, rebuilding, regulate, remove, requested, resigned, resume, resuming, reverse, satisfied, showed, split, substandard, successive, symbol, tier, Topic, treated, ultimate, uncertainty, uncompetitive, writing
Filing tables
Filing exhibits
Related press release
HROW similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-159159, 333-183488 and 333-198674 on Form S-8 and Registration Statement No. 333-198675 on Form S-3 of our report dated March 23, 2016, relating to the consolidated financial statements of Imprimis Pharmaceuticals, Inc. and subsidiaries, appearing in this Annual Report on Form 10-K of Imprimis Pharmaceuticals, Inc. for the year ended December 31, 2015.
/s/ KMJ Corbin & Company LLP
Costa Mesa, California
March 23, 2016